• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴管平滑肌瘤病表现为难治性乳糜胸和乳糜腹。

Lymphangioleiomyomatosis manifesting as refractory chylothorax and chyloperitoneum.

作者信息

Chen Yee-Shiuan, Memon Pauras

机构信息

Division of Medical Education, Department of Medicine, Barnes-Jewish Hospital, Saint Louis, Missouri, USA.

出版信息

BMJ Case Rep. 2019 Jul 11;12(7):e229958. doi: 10.1136/bcr-2019-229958.

DOI:10.1136/bcr-2019-229958
PMID:31300601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6626491/
Abstract

This is a rare case of sporadic lymphangioleiomyomatosis (S-LAM) manifesting as refractory chylothorax and chyloperitoneum. A middle-aged woman with unremarkable medical history presented with respiratory failure, abdominal distension and anasarca. She was found to have high-output chylous effusion that required chest tube drainage, as well as chylous ascites. Notably initial chest and abdominal CT did not reveal characteristic pulmonary cysts or the presence of angiomyolipomas suggestive of LAM. An extensive oncologic and infectious work-up was undertaken with negative findings. The chylous effusion was persistent and refractory to thoracic duct embolization, total parenteral nutrition with octreotide, and talc pleurodesis. Diagnosis of S-LAM was confirmed after repeat chest CT showed subtle pulmonary cystic changes, and serum vascular endothelial growth factor-D level was found to be elevated at 834 pg/mL. Patient was started on sirolimus therapy, but lost to follow-up after hospital discharge. Patient died approximately 1 year later.

摘要

这是一例罕见的散发性淋巴管平滑肌瘤病(S-LAM),表现为难治性乳糜胸和乳糜腹。一名既往病史无特殊的中年女性出现呼吸衰竭、腹胀和全身水肿。她被发现有高输出量的乳糜性积液,需要胸腔闭式引流,同时伴有乳糜腹水。值得注意的是,最初的胸部和腹部CT未显示特征性肺囊肿或提示LAM的血管平滑肌脂肪瘤。进行了广泛的肿瘤学和感染性检查,结果均为阴性。乳糜性积液持续存在,对胸导管栓塞、使用奥曲肽的全胃肠外营养及滑石粉胸膜固定术均无反应。重复胸部CT显示细微的肺囊性改变,且血清血管内皮生长因子-D水平升高至834 pg/mL后,S-LAM的诊断得以证实。患者开始接受西罗莫司治疗,但出院后失访。患者约1年后死亡。

相似文献

1
Lymphangioleiomyomatosis manifesting as refractory chylothorax and chyloperitoneum.淋巴管平滑肌瘤病表现为难治性乳糜胸和乳糜腹。
BMJ Case Rep. 2019 Jul 11;12(7):e229958. doi: 10.1136/bcr-2019-229958.
2
Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.西罗莫司联合奥曲肽治疗可减少西罗莫司难治性乳糜性胸腔积液合并淋巴管平滑肌瘤病。
Intern Med. 2017 Dec 15;56(24):3327-3331. doi: 10.2169/internalmedicine.8645-16. Epub 2017 Oct 11.
3
Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: a case report.女性散发性淋巴管平滑肌瘤病患者成功接受西罗莫司治疗后出现乳糜性腹水、乳糜性胸腔积液和下肢淋巴水肿:病例报告。
Lymphology. 2012 Jun;45(2):53-7.
4
Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.血清血管内皮生长因子-D在淋巴管平滑肌瘤病中的诊断及治疗监测潜力
Lymphology. 2016 Sep;49(3):140-9.
5
Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.西罗莫司治疗淋巴管平滑肌瘤病乳糜性胸腔积液的疗效
Ann Am Thorac Soc. 2013 Aug;10(4):408-9. doi: 10.1513/AnnalsATS.201212-125OC.
6
Pulmonary lymphangiomyomatosis (LAM) developing chylothorax.发展为乳糜胸的肺淋巴管平滑肌瘤病(LAM)。
Intern Med. 2000 Sep;39(9):738-41. doi: 10.2169/internalmedicine.39.738.
7
Chylothorax in lymphangioleiomyomatosis.淋巴管平滑肌瘤病中的乳糜胸
Chest. 2003 Feb;123(2):623-7. doi: 10.1378/chest.123.2.623.
8
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.西罗莫司治疗淋巴管平滑肌瘤病患者可导致乳糜性腹水和循环中的淋巴管平滑肌瘤细胞消失。
Chest. 2016 Aug;150(2):e29-32. doi: 10.1016/j.chest.2016.02.654.
9
Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.淋巴管平滑肌瘤病患者接受西罗莫司治疗后的功能改善:一项观察性研究。
Orphanet J Rare Dis. 2018 Feb 20;13(1):34. doi: 10.1186/s13023-018-0775-9.
10
Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).肺淋巴管平滑肌瘤病。69例患者的研究。肺部“孤儿”疾病研究与探索小组(GERM"O"P)。
Medicine (Baltimore). 1999 Sep;78(5):321-37. doi: 10.1097/00005792-199909000-00004.

引用本文的文献

1
Chylous Ascites as a Presentation of Lymphangioleiomyomatosis.乳糜性腹水作为淋巴管平滑肌瘤病的一种表现形式。
ACG Case Rep J. 2021 Mar 3;8(3):e00517. doi: 10.14309/crj.0000000000000517. eCollection 2021 Mar.
2
Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.以乳糜胸和(或)乳糜性腹水为表现的系统性红斑狼疮的临床特征:中国 15 例分析。
Medicine (Baltimore). 2020 Dec 18;99(51):e23661. doi: 10.1097/MD.0000000000023661.

本文引用的文献

1
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.淋巴管平滑肌瘤病的诊断与管理:高分辨率胸部计算机断层扫描、经支气管肺活检及胸膜疾病管理。美国胸科学会/日本呼吸学会官方临床实践指南。
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1337-1348. doi: 10.1164/rccm.201709-1965ST.
2
The use of octreotide in the treatment of chylothorax following cardiothoracic surgery.奥曲肽在心胸外科手术后乳糜胸治疗中的应用。
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):848-54. doi: 10.1093/icvts/ivv046. Epub 2015 Mar 16.
3
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.血清 VEGF-D 浓度作为淋巴管肌瘤病严重程度和治疗反应的生物标志物:多中心国际淋巴管肌瘤病西罗莫司疗效(MILES)试验的前瞻性分析。
Lancet Respir Med. 2013 Aug;1(6):445-52. doi: 10.1016/S2213-2600(13)70090-0.
4
Lymphangioleiomyomatosis - a wolf in sheep's clothing.淋巴管平滑肌瘤病——披着羊皮的狼。
J Clin Invest. 2012 Nov;122(11):3807-16. doi: 10.1172/JCI58709. Epub 2012 Nov 1.
5
[Simvastatin indused chylothorax].[辛伐他汀诱发的乳糜胸]
Rev Pneumol Clin. 2012 Feb;68(1):50-3. doi: 10.1016/j.pneumo.2011.06.008. Epub 2011 Aug 26.
6
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.血清血管内皮生长因子-D 可前瞻性地区分淋巴管平滑肌瘤病与其他疾病。
Chest. 2010 Sep;138(3):674-81. doi: 10.1378/chest.10-0573. Epub 2010 Apr 9.
7
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.欧洲呼吸学会淋巴管平滑肌瘤病诊断与管理指南。
Eur Respir J. 2010 Jan;35(1):14-26. doi: 10.1183/09031936.00076209.
8
Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients.非手术性胸导管栓塞治疗创伤性胸导管漏:109 例经验。
J Thorac Cardiovasc Surg. 2010 Mar;139(3):584-89; discussion 589-90. doi: 10.1016/j.jtcvs.2009.11.025. Epub 2009 Dec 29.
9
Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.淋巴管平滑肌瘤病患者血清血管内皮生长因子-D水平反映淋巴管受累情况。
Chest. 2009 May;135(5):1293-1300. doi: 10.1378/chest.08-1160.
10
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.淋巴管平滑肌瘤病中气胸的管理:对复发及肺移植并发症的影响
Chest. 2006 May;129(5):1274-81. doi: 10.1378/chest.129.5.1274.